Email a Friend
Print ArticleBreast Cancer Health Center
Breast Cancer: Treatment by Stage
Stage 0 Breast Cancer Treatment Options
Stage 0 breast cancer may still be precancerous, but it still needs treatment. Learn about its treatment options.
Stage 0 Breast Cancer Treatment Options
Stage 1 Breast Cancer Treatment Options
In Stage 1 breast cancer, the cancer hasn’t spread beyond the breast. Learn about its treatment options.
Stage 1 Breast Cancer Treatment Options
Stage 2 Breast Cancer Treatment Options
In stage 2 breast cancer, the cancer is in the breast and may also be in nearby lymph nodes. This article describes Stage 2 breast cancer treatment options.
Stage 2 Breast Cancer Treatment Options
Stage 3 Breast Cancer Treatment Options
In stage 3 breast cancer, cancer hasn’t spread far beyond the breast and nearby lymph nodes. Read about its treatment options.
Stage 3 Breast Cancer Treatment Options
Stage 4 Breast Cancer Treatment Options
Stage 4 breast cancer has spread beyond the breast and nearby lymph nodes to other parts of the body. Learn how it’s treated.
Stage 4 Breast Cancer Treatment Options
WebMD Medical Reference
Breast Cancer Guide
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.
October is National Breast Cancer Awareness Month, and a new study reveals why a high number of women with the disease still prefer to have the entire breast surgically removed instead of just the tumor. It's not always because doctors recommend it.
Most Popular
